HCP
66
8
CCI
31
3
EL
25
4
SWK
64
5
HCA
44
-2
SO
53
-4
CTSH
56
2
TSCO
49
5
KMI
67
-2
NEE
50
-5
DE
63
3
GPC
40
3
HPQ
63
6
JWN
48
6
CHRW
56
-3
VMC
57
4
CVX
47
3
MCHP
41
4
ROP
62
3
INTU
56
-4
HCP
66
8
CCI
31
3
EL
25
4
SWK
64
5
HCA
44
-2
SO
53
-4
CTSH
56
2
TSCO
49
5
KMI
67
-2
NEE
50
-5
DE
63
3
GPC
40
3
HPQ
63
6
JWN
48
6
CHRW
56
-3
VMC
57
4
CVX
47
3
MCHP
41
4
ROP
62
3
INTU
56
-4
Financhill
Back

Can Fite Biofarma Vs. BioLine Rx Industry Stock Comparison

Sell
42

CANF
Can Fite Biofarma

Last Price:
1.96
Seasonality Move:
-6.94%
Sell
32

BLRX
BioLine Rx

Last Price:
0.28
Seasonality Move:
5.57%
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.96. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.28. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 35.7 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.96 - 2.5) Sell
Bollinger Bands (100): (1.98 - 3.06) Sell

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 29.69 Sell
Chaikin Money Flow: -2669932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.39 - 0.49) Sell
Bollinger Bands (100): (0.46 - 0.74) Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2 Sell
20-day SMA: 2.11 Sell
50-day SMA: 2.21 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.01 Sell
20-day EMA: 2.11 Sell
50-day EMA: 2.24 Sell
200-day EMA: 2.45 Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.44 Sell
20-day SMA: 0.44 Sell
50-day SMA: 0.49 Sell
200-day SMA: 0.73 Sell
8-day EMA: 0.41 Sell
20-day EMA: 0.44 Sell
50-day EMA: 0.49 Sell
200-day EMA: 0.74 Sell

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):